Chemoinformaics analysis of (E)-2-Methyl-2-butenyl angelate
Molecular Weight | 168.236 | nRot | 3 |
Heavy Atom Molecular Weight | 152.108 | nRig | 3 |
Exact Molecular Weight | 168.115 | nRing | 0 |
Solubility: LogS | -2.129 | nHRing | 0 |
Solubility: LogP | 2.482 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 28.9727 |
nHD | 0 | BPOL | 18.6553 |
QED | 0.367 |
Synth | 2.911 |
Natural Product Likeliness | 1.759 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.008 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.355 |
MDCK | 0.0000265 |
BBB | 0.883 |
PPB | 0.856396 |
VDSS | 1.363 |
FU | 0.270265 |
CYP1A2-inh | 0.932 |
CYP1A2-sub | 0.793 |
CYP2c19-inh | 0.803 |
CYP2c19-sub | 0.742 |
CYP2c9-inh | 0.313 |
CYP2c9-sub | 0.157 |
CYP2d6-inh | 0.485 |
CYP2d6-sub | 0.171 |
CYP3a4-inh | 0.088 |
CYP3a4-sub | 0.266 |
CL | 10.883 |
T12 | 0.836 |
hERG | 0.011 |
Ames | 0.03 |
ROA | 0.015 |
SkinSen | 0.929 |
Carcinogencity | 0.043 |
EI | 0.992 |
Respiratory | 0.499 |
NR-Aromatase | 0.013 |
Antiviral | No |
Prediction | 0.937105 |